LHDX
NASDAQLucira Health Inc.
Latest news
25 items- SECSEC Form 15-12G filed by Lucira Health Inc.15-12G - Lucira Health, Inc. (0001652724) (Filer)
- SECLucira Health Inc. filed SEC Form 8-K: Other Events, Bankruptcy or Receivership8-K - Lucira Health, Inc. (0001652724) (Filer)
- SECSEC Form NT 10-Q filed by Lucira Health Inc.NT 10-Q - Lucira Health, Inc. (0001652724) (Filer)
- SECSEC Form S-8 POS filed by Lucira Health Inc.S-8 POS - Lucira Health, Inc. (0001652724) (Filer)
- SECSEC Form S-8 POS filed by Lucira Health Inc.S-8 POS - Lucira Health, Inc. (0001652724) (Filer)
- SECLucira Health Inc. filed SEC Form 8-K: Other Events, Financial Statements and Exhibits8-K - Lucira Health, Inc. (0001652724) (Filer)
- SECSEC Form NT 10-Q filed by Lucira Health Inc.NT 10-Q - Lucira Health, Inc. (0001652724) (Filer)
- SECLucira Health Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Completion of Acquisition or Disposition of Assets, Other Events, Financial Statements and Exhibits8-K - Lucira Health, Inc. (0001652724) (Filer)
- SECLucira Health Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Financial Statements and Exhibits8-K - Lucira Health, Inc. (0001652724) (Filer)
- SECSEC Form NT 10-K filed by Lucira Health Inc.NT 10-K - Lucira Health, Inc. (0001652724) (Filer)
- SECSEC Form 25-NSE filed by Lucira Health Inc.25-NSE - Lucira Health, Inc. (0001652724) (Subject)
- SECLucira Health Inc. filed SEC Form 8-K: Other Events8-K - Lucira Health, Inc. (0001652724) (Filer)
- SECLucira Health Inc. filed SEC Form 8-K: Other Events, Financial Statements and Exhibits8-K - Lucira Health, Inc. (0001652724) (Filer)
- INSIDERSEC Form 4: Engelson Erik T. exercised 574,666 shares at a strike of $0.82 and sold $657,306 worth of shares (634,666 units at $1.04), decreasing direct ownership by 72% to 23,282 units4 - Lucira Health, Inc. (0001652724) (Issuer)
- INSIDERSEC Form 4: Narido Richard Clavano sold $29,423 worth of shares (29,383 units at $1.00), decreasing direct ownership by 27% to 77,910 units4 - Lucira Health, Inc. (0001652724) (Issuer)
- INSIDERSEC Form 4: Collins Kevin Walter sold $73,841 worth of shares (111,819 units at $0.66), decreasing direct ownership by 32% to 234,903 units4 - Lucira Health, Inc. (0001652724) (Issuer)
- INSIDERSEC Form 4: Allen Anthony Joseph sold $8,405 worth of shares (8,405 units at $1.00), decreasing direct ownership by 6% to 136,520 units4 - Lucira Health, Inc. (0001652724) (Issuer)
- NEWSFDA Addresses 'Misinformation' Concerning Delayed Approval Of Lucira Health's COVID-19 & Flu Home TestThe FDA provided additional information about the agency's interactions and decisions regarding the emergency use authorization (EUA) of Lucira Health Inc's (OTC: LHDXQ) COVID-19 & Flu Home test. The statement comes due to concerns about the agency's length and timing of the EUA clearance and its bankruptcy filing, which said the delay in EUA financially hit the company. In an investor report, Lucira blamed the FDA's "protracted" authorization process for its combination Covid and flu at-home test. Lucira applied to the FDA for authorization of its novel test last May and expected to receive a thumbs-up by the end of summer before the flu season started. Canada authorized Lucira's test
- NEWSFDA's Regulatory Delay is The Reason For Novavax, Lucira Health's Failure: WSJ ReportFailures of Covid vaccine maker Novavax Inc (NASDAQ:NVAX) and diagnostic start-up Lucira Health Inc (NASDAQ:LHDX) show that companies often succeed or fail, owing to the whims of the government. Last week, while reporting Q4 earnings, Novavax raised doubts about its ability to remain in business and announced plans to cut spending. The Covid-19 vaccine was Novavax's first and only commercial product in its 36-year history, Wall Street Journal writes. However, the product flopped after successful trials thanks to regulatory delays and manufacturing hiccups. Operation Warp Speed awarded Novavax $1.6 billion to cover testing and manufacturing costs of its experimental vaccine in exchange f
- NEWSWhy Puma Biotechnology Shares Are Trading Lower By Over 15%? Here Are Other Stocks Moving In Friday's Mid-Day SessionGainers ObsEva SA (NASDAQ:OBSV) surged 86.6% to $0.1978 after dropping over 12% on Thursday. ObsEva recently announced strategic reorganization to consolidate operations in Switzerland. Altamira Therapeutics Ltd. (NASDAQ:CYTO) shares jumped 52.7% to $3.59 after the company said data from a recent peer-reviewed clinical study demonstrated Bentrio's superior nasal residence time and rheological properties. Lavoro Limited (NASDAQ:LVRO) gained 44.7% to $13.86. Lavoro and TPB Acquisition Corporation I announced completion of business combination. HUB Cyber Security (Israel) Ltd. (NASDAQ:HUBC) rose 36.6% to $1.71 after dipping 21% on Thursday. Seer, Inc. (NASDAQ:SEER) gained 35% to $5.68 a
- NEWS12 Health Care Stocks Moving In Friday's Intraday SessionGainers Seer (NASDAQ:SEER) shares moved upwards by 39.4% to $5.87 during Friday's regular session. As of 12:30 EST, Seer's stock is trading at a volume of 1.6 million, which is 437.5% of its average full-day volume over the last 100 days. The market value of their outstanding shares is at $367.7 million. The company's, Q4 earnings came out yesterday. Bullfrog AI Hldgs (NASDAQ:BFRG) shares rose 39.18% to $3.8. As of 12:30 EST, Bullfrog AI Hldgs's stock is trading at a volume of 4.2 million, which is 1055.1% of its average full-day volume over the last 100 days. The company's market cap stands at $21.4 million. Ardelyx (NASDAQ:ARDX) stock rose 36.18% to $3.94. Trading volume for Ardelyx's s
- NEWS12 Health Care Stocks Moving In Friday's Pre-Market SessionGainers Bullfrog AI Hldgs (NASDAQ:BFRG) stock increased by 47.6% to $4.03 during Friday's pre-market session. The company's market cap stands at $22.7 million. Rubius Therapeutics (NASDAQ:RUBY) shares moved upwards by 31.71% to $0.15. The company's market cap stands at $13.5 million. Ardelyx (NASDAQ:ARDX) shares rose 17.3% to $3.39. The market value of their outstanding shares is at $673.1 million. The company's, Q4 earnings came out yesterday. Akari Therapeutics (NASDAQ:AKTX) shares rose 16.24% to $0.38. The market value of their outstanding shares is at $28.2 million. Milestone Scientific (AMEX:MLSS) shares rose 13.92% to $0.9. The company's market cap stands at $62.8 million. Confor
- NEWSWhy Cano Health Shares Are Trading Lower By Around 23%? Here Are Other Stocks Moving In Thursday's Mid-Day SessionGainers Exela Technologies, Inc. (NASDAQ:XELA) shares surged 45% to $0.0701 after the company announced $51 million of new funding, amendment increases existing securitization facility to $185 million and other related transactions. BioRestorative Therapies, Inc. (NASDAQ:BRTX) shares jumped 34.7% to $3.76 after the company announced the United States Patent and Trademark Office has issued a notice of allowance for a patent application related to the Company's metabolic ThermoStem program. Diversified Healthcare Trust (NASDAQ:DHC) surged 30% to $1.21 after the company posted a profit for the fourth quarter. Desktop Metal, Inc. (NYSE:DM) gained 23% to $1.8550 after the company reported
- NEWS12 Health Care Stocks Moving In Thursday's Intraday SessionGainers BioRestorative Therapies (NASDAQ:BRTX) stock rose 32.4% to $3.69 during Thursday's regular session. BioRestorative Therapies's stock is trading at a volume of 28.4 million shares as of 12:30 EST. This is 189085.2% of its average full-day volume over the last 100 days. The company's market cap stands at $13.5 million. OncoSec Medical (NASDAQ:ONCS) shares rose 19.6% to $2.44. The current volume of 31.8 million shares is 2304.3% of OncoSec Medical's average full-day volume over the last 100 days (last updated at 12:30 EST). The company's market cap stands at $7.2 million. Biophytis (NASDAQ:BPTS) stock moved upwards by 19.56% to $0.5. The current volume of 7.6 million shares is 1275.2
- NEWS12 Health Care Stocks Moving In Thursday's Pre-Market SessionGainers Biophytis (NASDAQ:BPTS) stock moved upwards by 34.1% to $0.56 during Thursday's pre-market session. The company's market cap stands at $11.4 million. OncoSec Medical (NASDAQ:ONCS) shares rose 32.35% to $2.7. The market value of their outstanding shares is at $8.0 million. Avenue Therapeutics (NASDAQ:ATXI) stock increased by 30.35% to $1.46. The market value of their outstanding shares is at $8.0 million. BioRestorative Therapies (NASDAQ:BRTX) shares increased by 26.52% to $3.53. The company's market cap stands at $12.9 million. Apexigen (NASDAQ:APGN) shares rose 10.46% to $0.95. The company's market cap stands at $23.4 million. Chimerix (NASDAQ:CMRX) shares increased by 9.96% t
LHDX FAQ
6 questionsWhat does Lucira Health Inc. do?
Lucira Health, Inc., a medical technology company, focuses on the development and commercialization of infectious disease test kits. It develops a testing platform that produces molecular testing services. The company offers LUCIRA COVID-19 All-In-One Test Kit, a COVID-19 test kit; and develops influenza A and B viruses test kits. It has a patent license agreement with Eiken Chemical Co., Ltd.; technical services agreement with Jabil, Inc.; and manufacturing services agreement with Jabil MSA. The company was formerly known as DiAssess Inc. and changed its name to Lucira Health, Inc. in...Where does LHDX stock trade?
Lucira Health Inc. (LHDX) is listed on NASDAQ.What sector and industry is LHDX in?
Lucira Health Inc. operates in the Health Care sector, Biotechnology: Electromedical & Electrotherapeutic Apparatus industry.When did Lucira Health Inc. go public?
Lucira Health Inc. (LHDX) completed its IPO in 2021.What companies are similar to LHDX?
Notable peers in the same industry include MDT (Medtronic plc.), MASI (Masimo Corporation), SEAS (SeaWorld Entertainment Inc.), TMDX (TransMedics Group Inc.), LIVN (LivaNova PLC). Compare LHDX side-by-side with any of them on Quantisnow.How can I track LHDX on Quantisnow?
Quantisnow aggregates Lucira Health Inc.'s SEC filings, analyst ratings, insider transactions, FDA approvals, and press releases the moment they hit the wire (Wall Street's wire, on your screen.). Follow LHDX to receive live email and push alerts on every new disclosure.